Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Fattening up my position .
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by counterintuitive247on Dec 23, 2016 1:00pm
201 Views
Post# 25640613

Fattening up my position .

Fattening up my position . This is setting up really nicely. Bottomed out at 2.26 a week ago and now some building of shares followed by some news on activity. Next milestone coming in Jan, get in now and watch this be a solid performer for 2017.

Some of you seem to know a little bit about this technology (long investors) and the health system. What is the time length of a trial, and how many systems could potentially be needed by 1 hospital like Mount Sinai?



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities